Visualising success: Check out the infographic, video, and posters explaining H2O

It’s not always easy to explain something as technical and complex as the challenges and possibilities of using health data! That’s why we have created a video, an infographic, and posters highlighting the workings and benefits of H2O.

In under two-and-a-half minutes, this video explains the role of data in treating disease and the possibilities enabled by H2O in terms of patient empowerment and better conversations with healthcare providers. It also briefly shows how H2O secures patient data and can contribute to enhancing both health research and the sustainability and efficiency of healthcare systems.

Our infographic on patient-driven healthcare follows the journey of a patient, Lisa, as she uses H2O to track her outcomes and thus enjoy benefits such as having more effective conversations with her caregivers and better tracking and comparison of her treatment results. The visual also shows what Lisa can choose to do with her data, such as sharing it with relatives, or for research purposes.

Be sure to share these far and wide! The video especially can be posted on social media platforms, while the infographic can be shared both virtually and printed to be put on your office wall for educational purposes.

Other languages:

infographic

Additionally, posters in different languages have been created for patient organizations and hospitals to use and spread the word on H2O. Check them out!

ACKNOWLEDGEMENT

H2O has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945345. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Trial Nation and JDRF.

DISCLAIMER: this website reflects only the author’s view. Neither IMI, nor EFPIA, nor the European Commission, nor the JU are liable for any use that may be made of the information it contains.

About IMI

The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It works to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI was the world’s biggest public-private partnership (PPP) in the life sciences until its successor, the Innovative Health Initiative (IHI), was established in 2021. www.ihi.europa.eu